Effects of lead time, length bias, and false-negative assurance on screening for breast cancer
- 15 March 1993
- Vol. 71 (6) , 1998-2005
- https://doi.org/10.1002/1097-0142(19930315)71:6<1998::aid-cncr2820710613>3.0.co;2-p
Abstract
This article presents a model of breast cancer screening programs. The model shows the effects of the screening threshold, screen sensitivity, and false-negative assurance on the cumulative mortality rate in the screened population. It shows that factors of screen design and a penalty associated with false-negative assurance can result in excess mortality rates in screened populations-especially in those age classes in which the incidence of rapidly growing tumors is high. Factors related to the magnitude of this effect are described.Keywords
This publication has 7 references indexed in Scilit:
- Tumor Growth Rate and Prognosis of Breast Cancer Mainly Detected by Mass ScreeningJapanese Journal of Cancer Research, 1990
- Impact of a priori medical decisions on screening for breast cancer.Radiology, 1989
- Analysis of Breast Cancer Mortality and Stage Distribution by Age for the Health Insurance Plan Clinical TrialJNCI Journal of the National Cancer Institute, 1988
- What is the optimum interval between mammographic screening examinations — An analysis based on the latest results of the Swedish two-county breast cancer screening trialBritish Journal of Cancer, 1987
- Breast cancer: age-specific growth rates and screening strategies.Radiology, 1986
- Inferring the natural time history of breast cancer: Implications for tumor growth rate and early detectionBreast Cancer Research and Treatment, 1984
- The gross rates of growth of human mammary carcinomaCancer, 1972